https://www.linkedin.com/pulse/latest-analyst-ratings-mlearningintelligence-a4fhe/?trk=article-ssr-frontend-pulse_more-articles_related-content-card
- Echelon Wealth Partners' Stefan Quenneville issued BUY ratings for Valeo Pharma (TSE:VPH) and POET Technologies (TSE:PTK), holding a very low 0.38 and moderate 3.65-star ratings, respectively. The target prices are $0.60 (82.89% upside) and $3.00 (153.06% upside).